Top Markets
#1 MowCat MowCat +48.59%
#2 Bitway Bitway +26.49%
#3 Velvet Velvet +23.21%
#4 aPriori aPriori +19.57%
#5 OVERTAKE OVERTAKE +19.49%
#6 Biconomy Biconomy +15.42%
#7 Derive Derive +14.72%
#8 Zerebro Zerebro +13.81%
#9 Fake World Assets Fake World Assets +12.67%
#10 Perle Perle +11.13%
Coin of the day
MowCat MowCat
設定
言語
日本
通貨
USD
テーマ
Nicox S.A. Nicox S.A.

Nicox S.A.

COX
株式のランク #34243
Nicox S.A. is an ophthalmology enterprise operating both within France and... Nicox S.A. is an ophthalmology enterprise operating both within France and globally, focused on developing therapies to safeguard vision and enhance overall eye health. Its leading investigational drug, NCX 470, an innovative nitric oxide-donating prostaglandin analog designed to decrease intraocular pressure in individuals with open-angle glaucoma or ocular hypertension, is currently undergoing Phase 3 clinical trials. Furthermore, the company is progressing NCX 4251, a specialized fluticasone formulation, through a Phase 2b clinical trial for the management of acute exacerbations of blepharitis, as well as NCX 1728. Nicox also provides VYZULTA, a latanoprostene bunod ophthalmic solution for treating open-angle glaucoma or ocular hypertension, and ZERVIATE, a cetirizine ophthalmic solution to relieve ocular itching related to allergic conjunctivitis. The company, established in 1996, has its main office situated in Valbonne, France.
株価
$0.6379482
最終同期: 2023-05-22
時価総額
$5.98M
変化（1日）
-0.44%
変化（1年）
0.00%
国
FR
取引 Nicox S.A. (COX)

カテゴリー

Healthcare
Nicox S.A.（COX）の株式分割履歴
Nicox S.A.株（シンボル：COX）は合計で0回の株式分割を実施しました。
最新の株式分割はAug 16, 2026に行われました。
Aug 16, 2026より前に購入されたCOX株は、現在0COX株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE